[1]
P. Palani, V. Sharmila, T. Arun Babu, and G. K. K., “Efficacy of cabergoline in the prevention of severe ovarian hyperstimulation syndrome in high-risk women undergoing assisted reproductive technology treatment”, Int J Reprod Contracept Obstet Gynecol, vol. 11, no. 8, pp. 2147–2151, Jul. 2022.